Stock listing
BSE:STAR Strides Pharma Science Ltd Share Price
Indian listing (BSE) of Strides Pharma Science Ltd · home listing NSE:STAR
Follow Strides Pharma Science Ltd into a list and get an email when it puts out news.
Home listing price · NSE:STAR
₹967.30 INR +9.20 (+1.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NSE:STAR
- Day range
- ₹956.10 – ₹982.00 INRNov 20, 2026
- Volume
- 232,614 sharesNov 20, 2026
- Market cap
- ₹89.16B INRAt the close on Nov 20, 2026 · price × 92.17M shares outstanding
- 52-week range
- ₹768.65 – ₹1,260.90 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹440.7M INRMedian day 231,125 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:STAR · Home | ₹967.30 INR | +9.20 (+1.0%) | 232,614 | ₹982.00 | ₹982.00 | ₹956.10 | ₹958.10 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:STAR · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹967.30 | +9.20 | +1.0% | ₹982.00 | ₹982.00 | ₹956.10 | 232,614 | |
| ₹958.10 | -24.00 | -2.4% | ₹983.00 | ₹990.50 | ₹956.70 | 281,333 | |
| ₹982.10 | -4.00 | -0.4% | ₹980.50 | ₹1,000.00 | ₹973.00 | 238,815 | |
| ₹986.10 | -28.50 | -2.8% | ₹1,015.00 | ₹1,024.70 | ₹979.70 | 148,808 | |
| ₹1,014.60 | +5.30 | +0.5% | ₹1,009.30 | ₹1,020.80 | ₹1,004.50 | 128,959 | |
| ₹1,009.30 | +9.90 | +1.0% | ₹1,001.00 | ₹1,017.50 | ₹985.10 | 381,960 | |
| ₹999.40 | -2.80 | -0.3% | ₹1,008.30 | ₹1,016.00 | ₹988.00 | 379,125 | |
| ₹1,002.20 | +2.60 | +0.3% | ₹1,033.10 | ₹1,039.90 | ₹1,000.00 | 198,743 | |
| ₹999.60 | -8.00 | -0.8% | ₹1,002.60 | ₹1,009.00 | ₹991.80 | 186,978 | |
| ₹1,007.60 | -6.60 | -0.7% | ₹1,025.00 | ₹1,028.10 | ₹993.60 | 438,710 | |
| ₹1,014.20 | -23.10 | -2.2% | ₹1,034.00 | ₹1,047.80 | ₹1,010.00 | 184,808 | |
| ₹1,037.30 | +0.40 | 0.0% | ₹1,040.00 | ₹1,055.00 | ₹1,010.40 | 495,561 | |
| ₹1,036.90 | -31.90 | -3.0% | ₹1,067.30 | ₹1,067.30 | ₹1,013.90 | 407,966 | |
| ₹1,068.80 | -28.70 | -2.6% | ₹1,050.00 | ₹1,076.90 | ₹972.00 | 2,677,933 | |
| ₹1,097.50 | +11.90 | +1.1% | ₹1,087.40 | ₹1,105.00 | ₹1,087.40 | 203,597 | |
| ₹1,085.60 | -7.70 | -0.7% | ₹1,093.30 | ₹1,109.90 | ₹1,077.40 | 396,024 | |
| ₹1,093.30 | +60.20 | +5.8% | ₹1,025.50 | ₹1,116.40 | ₹1,025.50 | 787,204 | |
| ₹1,033.10 | +18.30 | +1.8% | ₹1,006.50 | ₹1,053.90 | ₹1,001.00 | 281,520 | |
| ₹1,014.80 | +16.40 | +1.6% | ₹1,000.00 | ₹1,023.60 | ₹980.40 | 312,085 | |
| ₹998.40 | -26.90 | -2.6% | ₹1,015.00 | ₹1,029.80 | ₹994.20 | 223,577 | |
| ₹1,025.30 | -4.00 | -0.4% | ₹1,021.00 | ₹1,031.00 | ₹1,002.70 | 144,622 | |
| ₹1,029.30 | -15.90 | -1.5% | ₹1,050.00 | ₹1,050.00 | ₹1,015.90 | 224,715 | |
| ₹1,045.20 | -14.70 | -1.4% | ₹1,060.00 | ₹1,066.00 | ₹1,040.00 | 207,930 | |
| ₹1,059.90 | -24.90 | -2.3% | ₹1,080.10 | ₹1,089.20 | ₹1,051.30 | 253,392 | |
| ₹1,084.80 | -10.70 | -1.0% | ₹1,087.00 | ₹1,094.00 | ₹1,071.70 | 184,350 | |
| ₹1,095.50 | -0.70 | -0.1% | ₹1,086.30 | ₹1,107.00 | ₹1,063.00 | 304,227 | |
| ₹1,096.20 | +10.90 | +1.0% | ₹1,082.00 | ₹1,103.40 | ₹1,080.30 | 80,618 | |
| ₹1,085.30 | -10.00 | -0.9% | ₹1,095.00 | ₹1,102.20 | ₹1,072.00 | 189,136 | |
| ₹1,095.30 | -5.30 | -0.5% | ₹1,100.60 | ₹1,106.10 | ₹1,067.00 | 420,852 | |
| ₹1,100.60 | +11.90 | +1.1% | ₹1,085.10 | ₹1,109.00 | ₹1,076.70 | 202,258 | |
| ₹1,088.70 | +2.00 | +0.2% | ₹1,081.20 | ₹1,096.20 | ₹1,074.00 | 138,279 | |
| ₹1,086.70 | +1.90 | +0.2% | ₹1,087.00 | ₹1,109.90 | ₹1,077.60 | 108,287 | |
| ₹1,084.80 | 0.00 | 0.0% | ₹1,084.80 | ₹1,084.80 | ₹1,084.80 | 0 | |
| ₹1,084.80 | -35.20 | -3.1% | ₹1,108.40 | ₹1,122.00 | ₹1,076.00 | 340,843 | |
| ₹1,120.00 | -52.60 | -4.5% | ₹1,167.00 | ₹1,174.50 | ₹1,110.00 | 447,494 | |
| ₹1,172.60 | +21.20 | +1.8% | ₹1,143.10 | ₹1,182.50 | ₹1,131.00 | 229,635 | |
| ₹1,151.40 | -33.50 | -2.8% | ₹1,175.80 | ₹1,186.00 | ₹1,148.20 | 115,834 | |
| ₹1,184.90 | -17.90 | -1.5% | ₹1,202.80 | ₹1,209.60 | ₹1,177.20 | 143,012 | |
| ₹1,202.80 | -20.50 | -1.7% | ₹1,222.20 | ₹1,233.10 | ₹1,199.30 | 126,615 | |
| ₹1,223.30 | +5.90 | +0.5% | ₹1,217.00 | ₹1,242.20 | ₹1,217.00 | 153,250 | |
| ₹1,217.40 | -17.70 | -1.4% | ₹1,234.20 | ₹1,246.70 | ₹1,195.50 | 285,056 | |
| ₹1,235.10 | +15.30 | +1.3% | ₹1,230.00 | ₹1,260.90 | ₹1,217.40 | 421,704 | |
| ₹1,219.80 | +19.60 | +1.6% | ₹1,202.60 | ₹1,229.40 | ₹1,200.00 | 282,913 | |
| ₹1,200.20 | +16.30 | +1.4% | ₹1,180.00 | ₹1,214.90 | ₹1,162.00 | 225,030 | |
| ₹1,183.90 | +33.30 | +2.9% | ₹1,153.40 | ₹1,192.00 | ₹1,102.00 | 398,309 | |
| ₹1,150.60 | -32.80 | -2.8% | ₹1,183.00 | ₹1,203.00 | ₹1,127.00 | 421,480 | |
| ₹1,183.40 | 0.00 | 0.0% | ₹1,183.40 | ₹1,183.40 | ₹1,183.40 | 0 | |
| ₹1,183.40 | -33.60 | -2.8% | ₹1,199.90 | ₹1,215.90 | ₹1,179.00 | 161,625 | |
| ₹1,217.00 | +21.30 | +1.8% | ₹1,189.00 | ₹1,223.00 | ₹1,159.70 | 304,120 | |
| ₹1,195.70 | +8.30 | +0.7% | ₹1,187.40 | ₹1,217.00 | ₹1,181.30 | 376,096 | |
| ₹1,187.40 | +8.60 | +0.7% | ₹1,169.00 | ₹1,206.90 | ₹1,155.30 | 491,962 | |
| ₹1,178.80 | +119.20 | +11.2% | ₹1,058.70 | ₹1,187.60 | ₹1,045.00 | 2,617,272 | |
| ₹1,059.60 | +6.00 | +0.6% | ₹1,053.10 | ₹1,066.50 | ₹1,040.00 | 217,190 | |
| ₹1,053.60 | +5.80 | +0.6% | ₹1,053.90 | ₹1,073.00 | ₹1,043.10 | 189,318 | |
| ₹1,047.80 | +23.60 | +2.3% | ₹1,009.40 | ₹1,050.10 | ₹1,009.40 | 327,406 | |
| ₹1,024.20 | -0.80 | -0.1% | ₹1,025.00 | ₹1,030.00 | ₹1,010.00 | 200,361 | |
| ₹1,025.00 | +5.10 | +0.5% | ₹1,029.00 | ₹1,038.10 | ₹1,006.90 | 426,871 | |
| ₹1,019.90 | +36.90 | +3.8% | ₹984.00 | ₹1,026.50 | ₹982.10 | 435,651 | |
| ₹983.00 | +0.10 | 0.0% | ₹982.90 | ₹994.40 | ₹978.90 | 94,124 | |
| ₹982.90 | -3.70 | -0.4% | ₹986.60 | ₹999.40 | ₹981.00 | 97,630 | |
| ₹986.60 | -7.00 | -0.7% | ₹999.00 | ₹1,001.90 | ₹976.00 | 209,006 | |
| ₹993.60 | +7.40 | +0.8% | ₹989.40 | ₹999.00 | ₹974.30 | 220,560 | |
| ₹986.20 | -6.80 | -0.7% | ₹998.00 | ₹1,003.00 | ₹970.60 | 341,043 | |
| ₹993.00 | +35.50 | +3.7% | ₹986.50 | ₹1,056.00 | ₹970.00 | 4,948,966 |
- Ticker
- BSE:STAR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- BSE
- Currency
- INR
What changed lately
Latest news release · Oct 29, 2026
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".
Latest deck · Oct 29, 2026
Q2 FY2027 Earnings Presentation
Earnings · 23 slides
Latest news
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".
Oct 29, 2026
Closed ₹1,068.80 (-2.6%) on Oct 30, 2026
Strides Pharma Science Ltd Press Release Aug 19 2026
Aug 19, 2026
Closed ₹993.00 (+3.7%) on Aug 20, 2026
Strides Pharma Science Ltd Press Release Jul 31 2026
Jul 31, 2026
Closed ₹1,025.00 (-4.5%) on Jul 31, 2026
Strides Pharma Science Ltd Press Release Jun 27 2026
Jun 27, 2026
Closed ₹1,103.40 (+2.0%) on Jun 29, 2026
Press Release May 18 2026
May 18, 2026
Closed ₹1,151.40 (-0.2%) on May 18, 2026
Press Release Mar 17 2026
Mar 17, 2026
Closed ₹907.05 (+3.6%) on Mar 18, 2026
Press Release (Revised) Feb 05 2026
Feb 5, 2026
Closed ₹863.90 (+0.2%) on Feb 6, 2026
Press Release Feb 05 2026
Feb 5, 2026
Closed ₹863.90 (+0.2%) on Feb 6, 2026
Strides Pharma Science Ltd Press Release Feb 05 2026
Feb 4, 2026
Closed ₹861.80 (-0.5%) on Feb 5, 2026
Press Release Jan 30 2026
Jan 30, 2026
Closed ₹836.55 (-4.6%) on Feb 2, 2026
Strides Pharma Science Ltd on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 10 in the last 12 months · 110 in all · newest Oct 29, 2026 · oldest 2020
- Decks
- 31 decks · latest Oct 29, 2026
Where Strides Pharma Science Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:STAR · Home listing | NSE | India | INR |
| BSE:STAR · This page | BSE | India | INR |
Valuation
P/E 14.5× against a median of 24.4×: the lowest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹105.1B INR
- P/E
- 14.5×
- EV/sales
- 2.0×
- EV/EBITDA
- 11.0×
- Price/book
- 2.6×
- Gross margin
- 42.4%
- Operating margin
- 14.2%
- Net margin
- 11.8%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma Science Ltd · NSE:STAR | US$962.1M | US$1.13B | 14.5× | 2.0× | 11.0× | 2.6× | 11.8% | 0.6× | n/a |
| Beijing Foyou Pharma Co., Ltd. Class A · SSE:601089 | US$1.03B | US$709.2M | 18.7× | 1.3× | n/a | 1.8× | 10.2% | 0.0× | n/a |
| Chengdu Easton Biopharmaceuticals Co., Ltd. Class A · SSE:688513 | US$994.9M | US$735.9M | 24.4× | 3.8× | n/a | 2.2× | 20.9% | 0.0× | n/a |
| Jiangsu Kanion Pharmaceutical Co. Ltd. Class A · SSE:600557 | US$981.0M | US$675.6M | 20.8× | 1.3× | n/a | 1.3× | 9.4% | 0.0× | n/a |
| Aarti Pharmalabs Limited · NSE:AARTIPHARM | US$969.4M | US$1.04B | 35.0× | 4.5× | 19.4× | 4.0× | 11.9% | 0.3× | n/a |
| CanSino Biologics, Inc. Class A · SSE:688185 | US$943.8M | US$802.4M | 226× | 5.0× | 26.7× | 1.3× | 2.6% | 0.2× | n/a |
| Zhejiang Tianyu Pharmaceutical Co. Ltd. Class A · SZSE:300702 | US$941.2M | US$934.7M | 90.7× | 1.6× | n/a | 1.7× | 1.8% | 0.1× | n/a |
| Chongqing Taiji Industry (Group) Co., Ltd. Class A · SSE:600129 | US$937.3M | US$910.3M | n/a | 0.6× | n/a | 1.8× | −0.2% | 0.1× | n/a |
| Jiangxi Fushine Pharmaceutical Co., Ltd. Class A · SZSE:300497 | US$928.5M | US$955.4M | 14.8× | 3.3× | n/a | 2.4× | 21.2% | 0.3× | n/a |
| KPC Pharmaceuticals, Inc. Class A · SSE:600422 | US$919.4M | US$815.3M | n/a | 1.2× | n/a | 1.3× | −6.3% | 0.1× | n/a |
| Changchun BCHT Biotechnology Co. Class A · SSE:688276 | US$906.3M | US$882.1M | n/a | 8.7× | n/a | 1.6× | −30.8% | 0.0× | n/a |
| Median of the others | US$942.5M | US$848.7M | 24.4× | 2.5× | 23.0× | 1.8× | 6.0% | 0.1× |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1338.67 INR · Analysts' mean
- EPS, year to Mar 2027
- 60.30 · 1 analyst
- Revenue, year to Mar 2027
- 57.01B · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Badree Komandur | MD & Group CEO |
| Ramaraju PVS | Executive Director |
Board
| Director | Role |
|---|---|
| Arun Kumar | Non-Executive Chairperson |
| Aditya Arun Kumar | Non-Executive Director |
| Ameet P Hariani | Independent Director |
| Badree Komandur | MD & Group CEO |
| Biren Gabhawala | Independent Director |
| Homi Rustam Khusrokhan | Independent Director |
| Kausalya Santhanam | Independent Director |
| Mukta Arora | Independent Director |
| Ramaraju PVS | Executive Director |
| Subir Chakraborty | Independent Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | May 22, 2024 · After close | −3.0% |
| Q3 2023 | Jan 24, 2023 · Before open | −5.4% |
| Q2 2023 | Nov 14, 2022 · Before open | +8.1% |
| Q1 2023 | Jul 29, 2022 · Before open | −0.9% |
| Q4 2022 | May 24, 2022 · Before open | −1.4% |
| Q3 2022 | Feb 10, 2022 · Before open | −1.1% |
| Quarter to Sep 30, 2021 | Nov 10, 2021 · Before open | −8.6% |
| Quarter to Jun 30, 2021 | Aug 6, 2021 · Before open | −6.3% |
| Quarter to Mar 31, 2021 | May 27, 2021 | −2.2% |
| Quarter to Dec 31, 2020 | Feb 4, 2021 · Before open | −0.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 23 slides | Oct 29, 2026 |
| Q2 FY27 Earnings Presentation | Earnings | 22 slides | Oct 29, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 16 slides | Jul 31, 2026 |
| Q4 FY2026 Earnings Presentation | Earnings | 23 slides | May 18, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 20 slides | May 18, 2026 |
| Q3 FY2026 Earnings Presentation | Earnings | 22 slides | Jan 30, 2026 |
| Q3 FY2026 Earnings Presentation | Earnings | 19 slides | Jan 30, 2026 |
| Shareholder Meeting (August 2025) | Shareholder meeting | 15 slides | Aug 7, 2025 |
| Q1 FY2026 Earnings Presentation | Earnings | 17 slides | Aug 7, 2025 |
| Q2 FY2025 Earnings Presentation | Earnings | 27 slides | Oct 24, 2024 |
All 31 decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.6B | 44.8B | 38.3B | 36.7B | 30.6B | 32.8B | 26.8B | 21.2B | 28.5B | 27.6B |
| Cost of revenue | 30.9B | 32.9B | 29.8B | 28.6B | 26.5B | 23.2B | 19.7B | 16.9B | 21.5B | 18.4B |
| Gross profit | 17.7B | 11.8B | 8.51B | 8.05B | 4.11B | 9.59B | 7.12B | 4.27B | 6.93B | 9.13B |
| Research and development | 679.3M | 595.4M | 638.6M | 893.9M | 1.06B | 1.04B | 1.29B | 1.19B | 1.58B | |
| Selling, general and administrative | 4.97B | 8.78B | 1.56B | 7.46B | 1.51B | 1.15B | 1.15B | 1.06B | 945.0M | 1.02B |
| Operating income | 7.23B | 5.18B | 3.02B | 1.24B | -2.52B | 3.15B | 1.89B | 855.1M | 2.56B | 4.03B |
| Depreciation and amortization | 2.02B | 1.92B | 2.21B | 2.43B | 2.33B | 2.06B | 1.88B | 1.72B | 1.50B | 1.26B |
| EBITDA | 9.25B | 7.11B | 5.23B | 3.67B | -189.4M | 5.21B | 3.76B | 2.57B | 4.06B | 5.30B |
| Interest expense | 1.79B | 2.49B | 2.80B | 2.61B | 1.77B | 1.50B | 1.55B | 789.7M | 1.96B | 1.83B |
| Income before tax | 6.69B | 4.87B | -1.15B | -2.86B | -6.53B | 2.75B | 546.8M | 624.0M | 799.5M | 3.43B |
| Income tax | 941.7M | 775.2M | 291.1M | -553.0M | -1.78B | 316.5M | 113.2M | -268.6M | 56.9M | 634.0M |
| Net income | 5.56B | 4.05B | -1.20B | -2.21B | -4.60B | 2.55B | 241.5M | 523.1M | -457.9M | 1.81B |
| Earnings per share, basic | 60.34 | 44.05 | -13.19 | -24.55 | -51.28 | 28.37 | 2.70 | 5.84 | -5.12 | 20.24 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.13B | 1.37B | 1.61B | 3.04B | 1.71B | 1.26B | 1.82B | 3.66B | 2.56B | 3.22B |
| Short-term investments | 157.9M | 860.6M | 1.29B | 572.0M | 134.6M | 1.49B | 1.66B | 4.27B | 3.52B | 12.9B |
| Receivables | 13.0B | 12.0B | 11.4B | 14.1B | 18.0B | 11.5B | -25.8M | -34.6M | 9.75B | 10.0B |
| Inventory | 16.3B | 12.8B | 11.3B | 11.5B | 11.7B | 12.0B | 7.83B | 8.71B | 5.52B | 7.38B |
| Current assets | 36.1B | 31.0B | 29.7B | 32.4B | 33.6B | 28.2B | 23.7B | 30.5B | 24.9B | 38.2B |
| Property, plant and equipment | 15.1B | 15.0B | 14.6B | 11.4B | 9.87B | 11.8B | ||||
| Goodwill | 5.94B | 5.47B | 5.29B | 5.14B | 4.86B | 4.81B | 4.29B | 13.7B | 9.15B | 9.67B |
| Total assets | 69.3B | 60.5B | 58.4B | 66.4B | 69.8B | 70.2B | 61.5B | 80.1B | 65.4B | 81.2B |
| Accounts payable | 13.1B | 10.3B | 8.52B | 9.82B | 10.7B | 11.3B | 7.98B | 8.89B | 7.12B | 7.74B |
| Current liabilities | 29.0B | 25.9B | 28.8B | 29.9B | 34.1B | 27.4B | 25.4B | 27.0B | 19.0B | 30.4B |
| Long-term debt | 5.52B | 5.71B | 6.71B | 11.4B | 8.36B | 8.83B | 6.04B | 18.1B | 15.5B | 16.3B |
| Total debt | 17.6B | 18.8B | 25.2B | 30.3B | 30.3B | 23.5B | 22.3B | 32.3B | 25.3B | 37.3B |
| Total liabilities | 37.8B | 34.6B | 37.7B | 44.7B | 45.9B | 42.0B | 35.6B | 52.0B | 39.3B | 52.4B |
| Shareholders' equity | 31.1B | 25.5B | 21.3B | 22.1B | 23.6B | 27.8B | 25.3B | 26.5B | 24.5B | 27.1B |
| Shares outstanding | 92.2M | 92.0M | 91.1M | 90.1M | 89.7M | 89.7M | 89.6M | 89.6M | 89.5M | 89.5M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5.39B | 6.84B | 7.01B | 444.1M | -2.58B | 4.81B | 2.05B | 600.5M | 1.87B | 2.88B |
| Capital spending | -4.18B | -2.42B | -1.18B | -949.4M | -1.43B | -2.97B | -1.50B | -3.29B | -4.03B | -6.82B |
| Free cash flow | 1.21B | 4.42B | 5.83B | -505.3M | -4.01B | 1.84B | 547.9M | -2.69B | -2.16B | -3.94B |
| Cash from investing | -1.78B | -896.9M | -1.50B | 3.02B | -1.19B | -5.21B | 13.1B | -1.48B | 5.83B | -7.05B |
| Cash from financing | -2.85B | -6.43B | -6.93B | -2.14B | 4.21B | -158.0M | -17.1B | 1.94B | -10.2B | 3.38B |
| Dividends paid | -368.6M | -229.9M | -135.2M | -224.3M | -179.2M | -1.54B | -179.5M | -442.9M | -357.5M | |
| Share buybacks | 3.91B | -1.82B | 2.38B | 12.3B | 10.3B | |||||
| Change in cash | 929.2M | -484.6M | -1.42B | 1.33B | 449.0M | -564.0M | -1.84B | 1.10B | -2.59B | -5.96B |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time". | Oct 29, 2026 | Results | NSE India |
| Strides Pharma Science Ltd Press Release Aug 19 2026 | Aug 19, 2026 | Other filings | NSE India |
| Strides Pharma Science Ltd Press Release Jul 31 2026 | Jul 31, 2026 | Results | NSE India |
| Strides Pharma Science Ltd Press Release Jun 27 2026 | Jun 27, 2026 | Operations update | NSE India |
| Press Release May 18 2026 | May 18, 2026 | Results | NSE India |
| Press Release Mar 17 2026 | Mar 17, 2026 | Acquisition or disposal | NSE India |
| Press Release Feb 05 2026 | Feb 5, 2026 | Other filings | NSE India |
| Strides Pharma Science Ltd Press Release Feb 05 2026 | Feb 4, 2026 | Other filings | NSE India |
| Press Release Jan 30 2026 | Jan 30, 2026 | Results | NSE India |
| Press Release Oct 31 2025 | Oct 31, 2025 | Results | NSE India |
All 87 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Oct 17 2025 | Oct 17, 2025 | Other filings | NSE India |
| Press Release Sep 08 2025 | Sep 8, 2025 | Operations update | NSE India |
| Press Release Jul 29 2025 | Jul 29, 2025 | Results | NSE India |
| Press Release May 22 2025 | May 22, 2025 | Results | NSE India |
| Press Release Apr 30 2025 | Apr 30, 2025 | Operations update | NSE India |
| Press Release Jan 30 2025 | Jan 30, 2025 | Results | NSE India |
| Press Release Jan 20 2025 | Jan 20, 2025 | Other filings | NSE India |
| Press Release Oct 24 2024 | Oct 24, 2024 | Quarterly report | NSE India |
| Strides Pharma Science Ltd Press Release Oct 16 2024 | Oct 15, 2024 | Other filings | NSE India |
| Press Release Sep 16 2024 | Sep 16, 2024 | Other filings | NSE India |
| Press Release Sep 11 2024 | Sep 11, 2024 | Operations update | NSE India |
| Press Release Sep 06 2024 | Sep 6, 2024 | Other filings | NSE India |
| Press Release May 22 2024 | May 22, 2024 | Results | NSE India |
| Press Release May 10 2024 | May 10, 2024 | Other filings | NSE India |
| Strides Pharma Science Ltd Press Release Apr 09 2024 | Apr 8, 2024 | Operations update | NSE India |
| Press Release Mar 05 2024 | Mar 5, 2024 | Other filings | NSE India |
| Press Release Jan 30 2024 | Jan 30, 2024 | Results | NSE India |
| Press Release Jan 25 2024 | Jan 25, 2024 | Operations update | NSE India |
| Press Release Dec 01 2023 | Dec 1, 2023 | Operations update | NSE India |
| Strides Pharma Science Ltd Press Release Nov 23 2023 | Nov 22, 2023 | Operations update | NSE India |
| Press Release Nov 21 2023 | Nov 21, 2023 | Operations update | NSE India |
| Press Release Oct 30 2023 | Oct 30, 2023 | Results | NSE India |
| Press Release Oct 04 2023 | Oct 4, 2023 | Operations update | NSE India |
| Press Release (Revised) Oct 03 2023 | Oct 3, 2023 | Other filings | NSE India |
| Press Release Sep 23 2023 | Sep 23, 2023 | Operations update | NSE India |
| Press Release Sep 14 2023 | Sep 14, 2023 | Operations update | NSE India |
| Press Release Sep 09 2023 | Sep 9, 2023 | Operations update | NSE India |
| Press Release Aug 30 2023 | Aug 30, 2023 | Other filings | NSE India |
| Press Release Aug 02 2023 | Aug 2, 2023 | Results | NSE India |
| Press Release Jul 04 2023 | Jul 4, 2023 | Other filings | NSE India |
| Press Release May 25 2023 | May 25, 2023 | Results | NSE India |
| Strides Pharma Science Ltd Press Release May 19 2023 | May 18, 2023 | Legal or regulatory action | NSE India |
| Strides Pharma Science Ltd Press Release May 03 2023 | May 2, 2023 | Operations update | NSE India |
| Strides Pharma Science Ltd Press Release Feb 24 2023 | Feb 23, 2023 | Operations update | NSE India |
| Press Release Jan 20 2023 | Jan 20, 2023 | Operations update | NSE India |
| Strides Pharma Science Ltd Press Release Jan 18 2023 | Jan 17, 2023 | Other filings | NSE India |
| Press Release Dec 28 2022 | Dec 28, 2022 | Other filings | NSE India |
| Press Release Dec 22 2022 | Dec 22, 2022 | Acquisition or disposal | NSE India |
| Press Release Nov 18 2022 | Nov 18, 2022 | Operations update | NSE India |
| Press Release Nov 14 2022 | Nov 14, 2022 | Other filings | NSE India |
| Press Release Sep 01 2022 | Sep 1, 2022 | Operations update | NSE India |
| Press Release Aug 26 2022 | Aug 26, 2022 | Other filings | NSE India |
| Press Release Aug 18 2022 | Aug 18, 2022 | Operations update | NSE India |
| Press Release Aug 08 2022 | Aug 8, 2022 | Other filings | NSE India |
| Press Release Aug 03 2022 | Aug 3, 2022 | Operations update | NSE India |
| Press Release Jun 24 2022 | Jun 24, 2022 | Other filings | NSE India |
| Press Release Jun 16 2022 | Jun 16, 2022 | Other filings | NSE India |
| Press Release Jun 10 2022 | Jun 10, 2022 | Operations update | NSE India |
| Press Release May 30 2022 | May 30, 2022 | Operations update | NSE India |
| Press Release May 15 2022 | May 15, 2022 | Other filings | NSE India |
| Press Release Mar 21 2022 | Mar 21, 2022 | Other filings | NSE India |
| Press Release Mar 17 2022 | Mar 17, 2022 | Other filings | NSE India |
| Press Release Mar 11 2022 | Mar 11, 2022 | Operations update | NSE India |
| Press Release Feb 21 2022 | Feb 21, 2022 | Operations update | NSE India |
| Press Release Jan 20 2022 | Jan 20, 2022 | Other filings | NSE India |
| Press Release Jan 17 2022 | Jan 17, 2022 | Operations update | NSE India |
| Press Release Dec 28 2021 | Dec 28, 2021 | Other filings | NSE India |
| Press Release Aug 06 2021 | Aug 6, 2021 | Other filings | NSE India |
| Press Release Jun 28 2021 | Jun 28, 2021 | Operations update | NSE India |
| Press Release Jun 14 2021 | Jun 14, 2021 | Operations update | NSE India |
| Press Release May 27 2021 | May 27, 2021 | Other filings | NSE India |
| Press Release Mar 19 2021 | Mar 19, 2021 | Other filings | NSE India |
| Press Release Mar 15 2021 | Mar 15, 2021 | Operations update | NSE India |
| Press Release Feb 24 2021 | Feb 24, 2021 | Other filings | NSE India |
| Press Release Feb 12 2021 | Feb 12, 2021 | Operations update | NSE India |
| Press Release Feb 04 2021 | Feb 4, 2021 | Other filings | NSE India |
| Press Release Jan 25 2021 | Jan 25, 2021 | Operations update | NSE India |
| Press Release Jan 15 2021 | Jan 15, 2021 | Other filings | NSE India |
| Press Release Jan 08 2021 | Jan 8, 2021 | Management or board change | NSE India |
| Press Release Dec 18 2020 | Dec 18, 2020 | Operations update | NSE India |
| Press Release Nov 23 2020 | Nov 23, 2020 | Operations update | NSE India |
| Press Release Oct 20 2020 | Oct 20, 2020 | Operations update | NSE India |
| Press Release Sep 22 2020 | Sep 22, 2020 | Other filings | NSE India |
| Press Release Sep 14 2020 | Sep 14, 2020 | Operations update | NSE India |
| Press Release Sep 03 2020 | Sep 3, 2020 | Operations update | NSE India |
| Press Release Aug 21 2020 | Aug 21, 2020 | Operations update | NSE India |
| Press Release Aug 19 2020 | Aug 19, 2020 | Other filings | NSE India |
Cap table
Built by 6ix from Strides Pharma Science Ltd’s releases
- Common shares
- 92,172,714
- Fully diluted
- 92,172,714
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 92,172,714 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 92,172,714 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aditya Arun Kumar | Non-Executive Director · Since at least Sep 9, 2025 |
| Ameet P Hariani | Independent Director · Since at least Nov 4, 2026 |
| Arun Kumar | Non-Executive Chairperson · Since at least Nov 6, 2026 |
| Badree Komandur | MD & Group CEO · Since at least Nov 6, 2026 |
| Biren Gabhawala | Independent Director · Since at least Nov 4, 2026 |
| Homi Rustam Khusrokhan | Independent Director · Since at least Nov 4, 2026 |
| Kausalya Santhanam | Independent Director · Since at least Nov 4, 2026 |
| Mukta Arora | Independent Director · Since at least Nov 4, 2026 |
| Ramaraju PVS | Executive Director · Since at least Nov 6, 2026 |
| Subir Chakraborty | Independent Director · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Strides Pharma Science Ltd.